Literature DB >> 2623280

[Socioeconomic effects of human brucellosis].

J D Colmenero Castillo, F P Cabrera Franquelo, S Hernández Márquez, J M Reguera Iglesias, A Pinedo Sánchez, A M Castillo Clavero.   

Abstract

The socio-economic cost of human brucellosis is analyzed. One hundred and seven patients are included in this study, 75 males (70.09%) and 32 females (29.91), diagnosed of brucellosis in the Internal Medicine Department of the Regional Hospital "Carlos Haya" in Málaga from the 1st of October 1984 to the 31st of December 1986. Thirty seven patients (34.57%) presented some kind of complication. Seventy eight cases (72.89%) were admitted to the hospital resulting in a total of 1.005 hospital admissions with a mean hospital stay of 12.88 days. The total economic cost was 30.724.962 pesetas with a mean patient cost of 287.149 pesetas. The total number of work absence days was 5.291 with a mean 101.7 days per patient and with an accumulated cost in this respect of 49.053.151 pesetas. The total money loss was 84.307.488 pesetas with a mean of 787.920 pesetas per patient. This high cost, together with the high incidence of the disease throughout most of our national territory, clearly justify the need for aggressive preventive measures.

Entities:  

Mesh:

Year:  1989        PMID: 2623280

Source DB:  PubMed          Journal:  Rev Clin Esp        ISSN: 0014-2565            Impact factor:   1.556


  3 in total

1.  Evaluation of recombinant porin (rOmp2a) protein as a potential antigen candidate for serodiagnosis of Human Brucellosis.

Authors:  Prachi Pathak; Ashu Kumar; Duraipandian Thavaselvam
Journal:  BMC Infect Dis       Date:  2017-07-11       Impact factor: 3.090

Review 2.  Caprine brucellosis: A historically neglected disease with significant impact on public health.

Authors:  Carlos A Rossetti; Angela M Arenas-Gamboa; Estefanía Maurizio
Journal:  PLoS Negl Trop Dis       Date:  2017-08-17

3.  Cystic echinococcosis in the Province of Álava, North Spain: the monetary burden of a disease no longer under surveillance.

Authors:  Hélène Carabin; Francisco J Balsera-Rodríguez; José Rebollar-Sáenz; Christine T Benner; Aitziber Benito; Juan C Fernández-Crespo; David Carmena
Journal:  PLoS Negl Trop Dis       Date:  2014-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.